Clinical drug trials enter electronic world
Pfizer is conducting what it calls the first-ever all-electronic drug trial, in which patients at home will report outcomes to the company through the Internet.
Say something
Pfizer is conducting what it calls the first-ever all-electronic drug trial, in which patients at home will report outcomes to the company through the Internet.
GE plans to invest $6 billion on healthcare GE Healthcare, the $17-billion healthcare arm of General Electric launched new, low […]
Pharma RFID market expected to hit US$ 1 trillion by 2020 The market for Radio Frequency Identification (RFID) applications in […]
US health insurer WellPoint Inc is developing a system that will use its 35m member database to monitor and more quickly identify potential safety problems of approved medicines.
Glenmark Pharmaceuticals has initiated voluntary recall of a skin ointment from the US after the drug exceeded the permissible impurity level.
Health information on the internet used to be shaped by doctors. Now it’s being shaped by patients. And it’s patients, not doctors, who are making the real progress in providing health information that delivers what people really want to know. But how do you know if this information and advice is trustworthy, and worth heeding?
As part of the open government initiative, the U.S. Food and Drug Administration launched a “transparency” website for its medical and radiological devices branch.
A new partnership of medical device makers with the cell-phone industry is being sought, to allow doctors to remotely monitor their patients’ heart rhythms, body temperature and breathing rates.
[This article was published in the June 2009 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
eHealth News
After facing massive losses coupled with regulatory hurdles in the American market, Ranbaxy Laboratories Ltd has chalked out plans to revamp its US business.
[This article was published in the May 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Business News
[This article was published in the March 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
The medical equipment market in India is growing at an annual rate of 15% and is expected to touch US$ 4.98 billion by 2012. With a highly unregulated environment in terms of quality, reliability, pricing and control, uncertainty rules the roost. Often, it�s a confusing maze for care providers and medical professionals, and the brunt of all this has to be borne solely by those at the end of the chain – �the patients� !
There is a dire need for a legal framework and a regulatory agency to look after the industry. How far have we reached? Is the Government taking the right steps? eHEALTH takes stock of the matter.
The LORENZ Life Sciences Group announced recently that Orchid Chemicals & Pharmaceuticals, located in Chennai, India has chosen docuBridge as its eCTD Publishing and Management solution.